Citation

Leviton A, Dammann O. Acta Paediatr. 2002; 91(1): 9-13.

Affiliation

Department of Neurology, Children's Hospital, Boston, MA 02115, USA. alan.leviton@tch.harvard.edu

Copyright

(Copyright © 2002, John Wiley and Sons)

DOI

unavailable

PMID

11883827

Abstract

The presence in blood of proteins normally confined to the cytoplasm of brain cells is considered peripheral evidence of brain damage. Only recently have these proteins been measured in the blood of children at risk of brain damage. To show the value and limitations of measuring these proteins, we review their biology and the adult literature that has correlated the blood concentrations of these proteins with lesion size and dysfunction. Conclusion: We conclude that brain damage markers will increasingly be measured in the blood of newborns and other children at risk of brain damage.

Language: en